CATALYST DOSSIER · UPDATED 2026-10-12
$AIBT biotech · convergence -25 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $AIBT?
Quantitative
Net Income (CY2026Q2) : $-537.0K (-10.4% YoY)
Catalysts
Multi-spoke convergence : 1 convergent signals fired: ftd
Risks
Position-sizing discipline : Conviction AVOID (-25 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
NFE via utilities r=-0.57 divergent (score 20) VIVK via utilities r=-0.57 divergent (score -4) KPTI via biotech r=+0.00 intra-sector (score 11) BRVO via biotech r=+0.00 intra-sector (score 5) PDSB via biotech r=+0.00 intra-sector (score 1) JAZZ via biotech r=+0.00 intra-sector (score 0)
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-08-27 sec_top_gappers +0.0% -25.0% — 2026-08-27 sec_top_moat_emerging +0.0% -25.0% — 2026-08-21 sec_top_gappers +0.0% -20.0% — 2026-08-21 sec_top_moat_emerging +0.0% -20.0% — 2026-08-20 sec_top_gappers +25.0% +25.0% ✓ hit 2026-08-20 sec_top_moat_emerging +25.0% +25.0% ✓ hit
Lifetime: 2/6 wins · hit-rate 33.3% on +2% intraday
Sympathy Basket NFE via utilities · score 20 VIVK via utilities · score -4 KPTI via biotech · score 11 BRVO via biotech · score 5 PDSB via biotech · score 1 JAZZ via biotech · score 0 Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.